北美内皮功能障碍市场预测至 2028 年 – 区域分析 – 按原因（高血压、糖尿病、高胆固醇血症、白塞氏病、肥胖等）、测试类型 [侵入性测试和非侵入性测试（流量介导）扩张、外周动脉张力测定 (PAT)、静脉闭塞体积描记术、循环标记等）] 和最终用户（医院、门诊手术中心、专科诊所等）
No. of Pages: 115 | Report Code: BMIRE00029161 | Category: Life Sciences
No. of Pages: 115 | Report Code: BMIRE00029161 | Category: Life Sciences
根据世界卫生组织 (WHO) 的数据，心血管疾病 (CVD)中风是全球主要死亡原因之一，每年约有 3000 万人中风。 CVD包括脑血管疾病、冠心病、风湿性心脏病和冠状动脉疾病(CAD)。 CAD是所有心血管疾病中最常见的疾病，其特征是脂质和免疫细胞在冠状动脉内皮下间隙积聚或动脉粥样硬化。它涉及血管内皮的炎症反应。 CAD的特征是由于动脉粥样硬化导致冠状动脉管腔变窄、痉挛或阻塞而导致心肌缺血、缺氧或坏死。它已成为全世界死亡的主要原因。根据美国疾病控制与预防中心 (CDC) 的数据，美国有超过 6000 万女性 (44%) 患有某种形式的心脏病。心脏病是美国女性死亡的主要原因，可以影响任何年龄段的女性。 2021 年，它导致 310,661 名女性死亡，即近五分之一的女性死亡。
根据美国心脏协会的数据，美国几乎一半的成年人患有某种类型的 CVD。预计到 2035 年，将有超过 1.3 亿人（即美国人口的 45.1%）患有某种类型的心血管疾病。因此，内皮功能障碍导致的心血管疾病的高患病率推动了市场的发展。
北美内皮功能障碍市场根据美国、加拿大和墨西哥三个主要国家进行分析。该地区的市场扩张可归因于心脏病发病率的增加和心脏病信息学投资的增加。由于 CAD 负担日益增加、医疗基础设施完善以及为开发先进的内皮功能障碍药物和设备而开展的研发活动等因素，美国拥有北美最大的内皮功能障碍市场规模。
北美内皮功能障碍市场细分为病因、测试类型、最终用户和国家。
根据病因，北美内皮功能障碍市场细分为高血压、高胆固醇血症、肥胖、糖尿病、白塞病疾病，以及其他。 2022年，高血压细分市场在北美内皮功能障碍市场份额最大。
根据测试类型，北美内皮功能障碍市场分为侵入性检测和非侵入性检测。到 2022 年，侵入性测试领域将占据更大的北美内皮功能障碍市场份额。非侵入性测试领域进一步细分为血流介导扩张、外周动脉张力测定 (PAT)、静脉闭塞体积描记术、循环标记物等。
根据最终用户，北美内皮功能障碍市场已分为医院、诊断中心、诊所等。 2022 年，医院细分市场占据北美最大的内皮功能障碍市场份额。
按国家/地区划分，北美内皮功能障碍市场分为美国、加拿大和墨西哥。 2022 年，美国将主导北美内皮功能障碍市场。
ZOLL Medical Corp、劳伦斯伯克利国家实验室、Endothelix Inc、Perimed AB、SMART Medical Ltd、Everist Health Inc 和 Medizinische Messtechnik GmbH 是其中一些公司该地区内皮功能障碍市场的领先公司。
Strategic insights for North America Endothelial Dysfunction involve closely monitoring industry trends, consumer behaviours, and competitor actions to identify opportunities for growth. By leveraging data analytics, businesses can anticipate market shifts and make informed decisions that align with evolving customer needs. Understanding these dynamics helps companies adjust their strategies proactively, enhance customer engagement, and strengthen their competitive edge. Building strong relationships with stakeholders and staying agile in response to changes ensures long-term success in any market.
| Report Attribute | Details |
|---|---|
| Market size in 2022 | US$ 951.83 Million |
| Market Size by 2028 | US$ 1,247.30 Million |
| Global CAGR (2022 - 2028) | 4.6% |
| Historical Data | 2020-2021 |
| Forecast period | 2023-2028 |
| Segments Covered |
By 病因
|
| Regions and Countries Covered | 北美
|
| Market leaders and key company profiles |
The regional scope of North America Endothelial Dysfunction refers to the geographical area in which a business operates and competes. Understanding regional nuances, such as local consumer preferences, economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved regions or adapting their offerings to meet regional demands. A clear regional focus allows for more effective resource allocation, targeted marketing, and better positioning against local competitors, ultimately driving growth in those specific areas.
The North America Endothelial Dysfunction Market is valued at US$ 951.83 Million in 2022, it is projected to reach US$ 1,247.30 Million by 2028.
As per our report North America Endothelial Dysfunction Market, the market size is valued at US$ 951.83 Million in 2022, projecting it to reach US$ 1,247.30 Million by 2028. This translates to a CAGR of approximately 4.6% during the forecast period.
The North America Endothelial Dysfunction Market report typically cover these key segments-
The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the North America Endothelial Dysfunction Market report:
The North America Endothelial Dysfunction Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:
The North America Endothelial Dysfunction Market report is valuable for diverse stakeholders, including:
Essentially, anyone involved in or considering involvement in the North America Endothelial Dysfunction Market value chain can benefit from the information contained in a comprehensive market report.
Office No. 1011, First floor, Farena Corporate Park, Magarpatta-Mundhwa road, Pune - 411028, Maharashtra, India
UK+442030260021, US:+16467917070
sales@businessmarketinsights.com
Get Free Sample For North America Endothelial Dysfunction Market
